DEERFIELD, Ill. (AP) — Medical products company Baxter International will acquire medical technology firm Hillrom for $10.5 billion in cash, the companies announced Thursday. Baxter will also absorb Hillrom's debt and cash, bringing the total value of the deal to $12.4 billion.
Baxter will pay Hillrom shareholders $156 per share, a 26% premium on its closing price on July 27, when speculation about a deal began to spread. Hillrom shares closed at $145.06 on Thursday and were up more than 3% in premarket trading, to $149.75.
Deerfield, Illinois-based Baxter, which offers essential hospital products including dialysis, IV solutions and other therapies and devices, had sales of $11.7 billion in 2020, with projected sales of $12.6 billion this year.
Hillrom, headquartered in Chicago, is focused on medical technology products and services such as smart beds, patient monitoring and diagnostic technologies and advanced surgical equipment. It has sales approaching $3 billion annually.
The deal has been agreed upon by both companies’ boards and is expected to close in early 2022, pending regulatory approval and a vote by Hillrom shareholders.
Baxter shares rose about 1% in premarket trading, to $78.40.
Before you consider Baxter International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Baxter International wasn't on the list.
While Baxter International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
